Cooperative Agreement U10CA035184

The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) received a $135,949 Project Grant award from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395), effective September 1, 2025, through August 31, 2030. This R50 Clinician Scientist Award supports the expansion of access and enrollment to precision medicine trials in acute myeloid leukemia (AML). The project addresses two critical barriers to trial enrollment: the limited...

Summary The Michigan Department of Health and Human Services (MDHHS) received a $1.236 million cooperative agreement award from the Centers for Disease Control and Prevention (CDC) under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800), effective August 30, 2025 through August 29, 2030. MDHHS will establish and coordinate a network of primary care clinics, health systems, and supporting partners to implement evidence-based interventions (EBIs) aimed at...

Federal Cooperative Agreement Summary Northwestern University's Robert H. Lurie Comprehensive Cancer Center (LCC) received a $1.139 million cooperative agreement from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395), awarded on April 28, 2026, with a completion date of February 29, 2032. As a Lead Academic Participating Site (LAPS) within the NCI National Clinical Trials Network (NCTN), the LCC will deliver enhanced infrastructure and operational...

Maryland Colorectal Cancer Control Program Summary The Maryland Department of Health, Prevention & Health Promotion Administration received a $510,000 Cooperative Agreement award from the Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800). The award, effective August 30, 2025, through August 29, 2030, funds the Maryland Colorectal Cancer...

Federal Grant Award Summary Mayo Clinic received a $667,710 Project Grant award from the National Cancer Institute under the Cancer Treatment Research program (CFDA 93.395) on March 20, 2026, with a completion date of February 28, 2031. The grant supports a randomized Phase 2 clinical trial investigating blood-based biomarkers to optimize treatment strategies for patients with oligometastatic castration-sensitive prostate cancer (OMCSPC). The research evaluates prostate cancer-derived...

Federal Cooperative Agreement Summary The University of Michigan received a $210,600 Cooperative Agreement from the National Cancer Institute under the Cancer Detection and Diagnosis Research Program (CFDA 93.394), effective September 1, 2025, through August 31, 2027. This award supports the analytical and clinical validation of an H3K27M circulating tumor DNA (ctDNA) assay designed to improve disease monitoring and early detection of progression in diffuse midline glioma (DMG) patients. The...

Award Summary The National Cancer Institute (NCI) awarded Kaiser Foundation Hospitals a $1.4 million Cooperative Agreement on September 8, 2025, under the Cancer Cause and Prevention Research program (CFDA 93.393) to adapt and implement an evidence-based patient navigation intervention for adolescent and young adult (AYA) cancer survivors. The two-year project, concluding August 31, 2027, addresses critical gaps in survivorship care for patients aged 15-39, including underutilization of...

NextGen Oncology Scholars Program Summary Wayne State University received a $159,450 Project Grant award from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398) effective August 15, 2025 through July 31, 2030. The award funds the "NextGen Oncology Scholars: Nurturing Tomorrow's Pioneers" program, which provides structured educational and research training for undergraduate scholars to prepare them for graduate studies and careers in cancer...

Federal Project Grant Award Summary The National Cancer Institute (NCI), under its Cancer Research Manpower program (CFDA 93.398), awarded $162,305.00 to the University of Michigan to support mentored research career development in cancer biology. Awarded on August 1, 2025, with a project period extending through July 31, 2030, this grant funds a K08 mentored research career development award for Dr. Peggy Hsu, MD, PhD. The project supports comprehensive investigation into early-stage Anaplastic...

The Kentucky Department for Public Health (KDPH) received a $1,065,610 Cooperative Agreement award dated August 30, 2025, from the Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800). The five-year award, extending through August 29, 2030, funds KDPH to implement evidence-based interventions designed to increase colorectal cancer screening...